中文版 | English

在结果中检索

IMR OpenIR

浏览/检索结果: 共4条，第1-4条 帮助

已选(0)清除 条数/页：   排序方式：
Individualized Antiplatelet Therapy: A Long Way to Go 期刊论文
Chinese Medical Journal, 2018, 卷号: 131, 期号: 12, 页码: 1387-1389
作者:  Han YaLing
收藏  |  浏览/下载：99/0  |  提交时间：2021/02/02
Acute Coronary Syndrome  Medicine  R  Antiplatelet Therapy  Cardiovascular Disease  Percutaneous Coronary Intervention  
Safety and Necessity of Antiplatelet Therapy on Patients Underwent Endovascular Aortic Repair with Both Stanford Type B Aortic Dissection and Coronary Heart Disease 期刊论文
Chinese Medical Journal, 2017, 卷号: 130, 期号: 19, 页码: 2321-2325
作者:  He RuiXia;  Zhang Lei;  Zhou TieNan;  Yuan WenJie;  Liu YanJie;  Fu WenXia;  Jing QuanMin;  Liu HaiWei;  Wang XiaoZeng
收藏  |  浏览/下载：151/0  |  提交时间：2021/02/02
Acute Coronary Syndrome  Medicine  R  Antiplatelet  Aortic Dissection  Endovascular Aortic Repair  
Efficacy and safety of individually tailored antiplatelet therapy in patients with acute coronary syndrome after coronary stenting: a single center, randomized, feasibility study 期刊论文
JOURNAL OF GERIATRIC CARDIOLOGY, 2015, 卷号: 12, 期号: 1, 页码: 23-29
作者:  Zhu HongChang;  Li Yi;  Guan ShaoYi;  Li Jing;  Wang XiaoZeng;  Jing QuanMin;  Wang ZuLu;  Han YaLing
收藏  |  浏览/下载：174/0  |  提交时间：2021/02/02
PATIENTS SHOWING RESISTANCE  ASPIRIN AND/OR RESISTANCE  CARDIOVASCULAR EVENTS  MYOCARDIAL-INFARCTION  CLOPIDOGREL RESISTANCE  RESPONSE VARIABILITY  PLATELET INHIBITION  DRUG-RESISTANCE  INCREASED RISK  INTERVENTION  Acute coronary syndrome  Antiplatelet therapy  Clopidogrel  Coronary stenting  
A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation 期刊论文
CHINESE MEDICAL JOURNAL, 2009, 卷号: 122, 期号: 7, 页码: 793-797
作者:  Han Yaling;  Wang Bin;  Li Yi;  Xu Kai;  Wang Shouli;  Jing Quanmin;  Wang Zulu;  Wang Dongmei;  Ma Yingyan;  Wang Geng
收藏  |  浏览/下载：101/0  |  提交时间：2021/02/02
MYOCARDIAL-INFARCTION  ANTIPLATELET THERAPY  PLATELET-AGGREGATION  ARTERY-DISEASE  DIABETES-MELLITUS  INTERVENTION  TRIAL  RESPONSIVENESS  VARIABILITY  INHIBITION  angioplasty, transluminal, percutaneous coronary  clopidogrel  maintenance dose